An extension study of Amgen's experimental obesity drug MariTide found that it helped people maintain weight loss while a ...

The drug, orforglipron, won a fast-track review voucher from the U.S. Food and Drug Administration that could cut review ...

Low-income Californians who use GLP-1s for weight loss lost their coverage at the start of the new year, with officials ...

Discontinuing obesity medicines often means the weight comes back and people lose the cardiovascular and metabolic benefits ...

Clinical trials show retatrutide, Eli Lilly's new triple-agonist drug, delivered 24.2% weight loss in 48 weeks and the ...

The medication, available at a lower cost, is an alternative to injections and increases accessibility for patients, some ...

US at a fraction of the cost of injectable versions – has rather stolen their thunder. Patients used to paying more than ...

People who took both Zepbound and an anti-inflammatory drug saw a greater improvement of their psoriatic arthritis symptoms.

Eli Lilly said on Thursday a late-stage trial showed its weight-loss drug Zepbound, used with its psoriatic arthritis ...

A new study finds that people who quit weight-loss medications, including GLP-1 drugs, regain weight four times faster than ...

According to research published by the British Medical Journal (BMJ), those using weight-loss injection drugs could also ...

Bariatric surgery far outperformed GLP-1 weight loss drugs in a new real-world comparison of more than 50,000 patients. Two ...